Home › Funds › ALPINE ASSOCIATES MANAGEMENT INC. › APGE
ALPINE ASSOCIATES MANAGEMENT INC. position in APGE
APOGEE THERAPEUTICS INC
ALPINE ASSOCIATES MANAGEMENT INC. reported holding 57,900 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.7M, representing 0.48% of its reported portfolio and ranking #50 among its reported holdings. ALPINE ASSOCIATES MANAGEMENT INC. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ALPINE ASSOCIATES MANAGEMENT INC.'s APGE position evolved
ALPINE ASSOCIATES MANAGEMENT INC. first disclosed a stake in APGE in Q2 2026 at 57,900 shares (US$7.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 57.90K | $7.69M | New |
About APGE and 13F data
APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding APGE
- Venrock Adviser, LLC 8.49M sh · $1.13B · Q2 2026
- HBK INVESTMENTS L P 2.85M sh · $378.28M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.74M sh · $230.96M · Q2 2026
- GLAZER CAPITAL, LLC 1.64M sh · $217.82M · Q2 2026
- Paradigm Biocapital Advisors LP 1.58M sh · $209.23M · Q2 2026
- Pentwater Capital Management LP 1.43M sh · $189.14M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.31M sh · $173.63M · Q2 2026
- Affinity Asset Advisors, LLC 987.00K sh · $131.00M · Q2 2026
- First Light Asset Management, LLC 930.29K sh · $123.48M · Q2 2026
- Kryger Capital LLC 742.55K sh · $98.56M · Q2 2026
- First Trust Capital Management L.P. 625.18K sh · $82.98M · Q2 2026
- Remedium Capital Partners, LLC 586.69K sh · $77.87M · Q2 2026
More on ALPINE ASSOCIATES MANAGEMENT INC.
FAQ
How long has ALPINE ASSOCIATES MANAGEMENT INC. held APGE?
ALPINE ASSOCIATES MANAGEMENT INC. has disclosed APGE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is ALPINE ASSOCIATES MANAGEMENT INC.'s current position in APGE?
As of Q2 2026, ALPINE ASSOCIATES MANAGEMENT INC. holds 57.90K shares of APGE (APOGEE THERAPEUTICS INC), valued at $7.69M, representing 0.48% of its reported portfolio and ranking #50.
Has ALPINE ASSOCIATES MANAGEMENT INC. been buying or selling APGE?
In the latest 13F filing (Q2 2026), ALPINE ASSOCIATES MANAGEMENT INC. newly opened its position in APGE.
Which other funds hold APGE?
Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.